GlassScriptPhysician profile
Bradley Allen
NPI 1396132940
$1,438.37
in general payments reported to CMS, 2019-2025
11 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $146 · 2021: $301 · 2022: $126 · 2024: $443 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $432.40 | 2020-2021 | |
| Abbott Laboratories | $298.03 | 2021-2025 | Triclip |
| Ancora Heart, INC. | $188.68 | 2024 | Accucinch |
| Cardiac Dimensions, INC. | $133.01 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $121.44 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.10 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.35 | 2019 | |
| Boston Scientific Corporation | $32.56 | 2019-2025 | General - Ep |
| Sensible Medical Innovations INC | $18.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.42 | 2022 | |
| Philips North America LLC | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.